News
Elon Musk's chaotic foray into US politics has damaged his businesses, tanked Tesla stock, and triggered a Trump feud ...
When the U.S. Constitution was ratified, Congress was granted power to establish post offices and mail routes — many along ...
The new head of the Federal Aviation Administration said on Thursday the current state of the aging, understaffed U.S. air ...
US Stock Market Highlights: S&P 500, Nasdaq close at fresh records following solid Alphabet earnings
The S&P 500 and Nasdaq Composite ended at record highs on Thursday (July 24), supported by stronger-than-expected earnings ...
General Dynamics' second-quarter profit and revenue topped analyst estimates on Wednesday, driven by robust orders in its marine segment from Columbia- and Virginia-class submarine programs, boosting ...
Verizon Communications helped lead the way and rose 4%. The telecom giant reported a stronger profit for the latest quarter ...
American nuclear energy companies are securing multimillion-dollar investments as the Trump administration works to assert ...
If one theme has emerged in President Donald Trump’s second term, it’s this: He’s leveraged the power of his office for ...
Private equity has been largely the province of ultra-rich investors, endowments and pension funds. That may be changing.
Boeing shares are inching higher to start the week after a preliminary report was released over the weekend regarding the ...
After a landmark veto, Trump administration officials say they’re “open to reconsideration” and are negotiating a potential settlement of a lawsuit filed by Pebble’s developer.
Despite America's health policy turmoil, a number of ASX biotechs have announced big progress on their US expansion plans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results